Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.
Thanks el, always good to hear your perspective on daily action in market. Best wishes.
Hi El, volume high today and appear mostly buys. Might have expected more movement today or could TB offloading in background? Your thoughts appreciated..
Hi harhoo. Welcome to a small but select group of very long term holders. If you read back, a few faces will regularly be commenting, currently only a few, but possibly a large herd will arrive soon. This product is life changing as it allows clinical radiologists to identify cancer at a much earlier stage than currently available. It has taken years to develop but the first product is soon to be CE marked which will allow commercial sales around the world. It's a piece of software with algorithm and can be easily attached to any CT scanner and MRI scanner.
Evening all. That was a bit more like it! Alan Green of Brand Communications, our PR partner talked about our Fdbk today on ********** podcast. His narrative was very very bullish, "CE Mark materially changes profile of company, very very exciting company to be involved in, past and current revenues pales into comparison with the global potential of this series of products, Stonechecker licenced to use Texrad and doing very well" etc. He was so positive about forthcoming prospects for our company and did his PR job extremely well.
Evening everyone. Well, that was exciting wasn't it... Financial results as expected for me, increase in sales of Texrad research but not sufficient to cover increase in costs pending commercialization of clinical version. Delay in CE Mark for Texrad lung looks like due to lack of developers (CCI) compliance with ISO 13485, a quality management standard. Given the complexity of the long term development of Texrad to not consider the ISO aspect is relatively schoolboy stuff and doesn't reassure. I hope lesson is learnt going forward. It's still all about the CE Mark and what it means going forward. Disappointed no narrative on discussions with TB and TC 're disposal of shares in orderly fashion and agreement with TC extended to no dump until November and oh, it's November. Based on information provided by board members earlier in year I have some interesting questions for AGM.
Good luck El, am a big follower of your manager, great attitude to the game. Read his book, very funny stories.
Technically moving positive, about 20DMA and moved fractionally above ever tightening Bollinger for first time in months. Will be a major move soon, hopefully the right one! Always researching!
This annual event includes 16 presentation papers which used Texrad software for texture analysis by researchers. The scope and testing of this product is broadening and will achieve further positive recognition.
Hi Bob, expect overheads for year to be �700k + which would require recorded revenue at �500k+ for the second half of year to be profitable. Although revenues for second half expected to be significantly ahead am not sure they will result in overall profit for year. If they are then a really positive and unexpected result! We can't be certain what value is placed on Texrad research sales nor how they accrue the same. As usual it's all about looking ahead and although I guess we will accrue additional development costs with Future Processing then so product portfolio and commercial sales outlook Will look brighter. I still believe significant logistical support costs still being absorbed by GE Healthcare in Asia and this adds to my long term confidence. Lots of assumptions I know but in the absence of company news that's all we have to work with. Good weekend everyone.
Cheers El, we may not be a party to progress but it looks like someone is. Looks very leaky to me, market size is 75,000 and buying 700,000 and 500,000 without impact is curious. Price clearly being held in a very tight range. I am getting a tad excited about expected news whenever it may arrive.
Spoke to David Worlidge of Allenby Capital this morning. The results and AGM should under articles of association be before 30 November but he wasn't in a position to give specific. He did think it unlikely that AGM would be before 30 November which although is in breach of articles of association "is not uncommon". He saw no reason why results would not be out by 30 November but "it was out of his hands". Would have liked something more positive and would have expected NOMAD to be working to ensure articles are adhered to. Oh well. Market has reacted positively to FBDU updates.
Flying Brands yesterday explained how excited they are to be using our licensed software in clinical use for kidney stones. CE Mark expected in 6 weeks, immediate sales in Europe, India and China. FDA approval quarter 2 2018 opening up North America and already have one major customer in talks for commercialization. We receive royalties and licensing fees " should product achieve commercial success". Very positive news for FBDU and by implication also for Feedback plc. More confirmation that clinicians are engaging with exciting AI in medical imaging and the acceptance of Texrad as the medium for this as a leader in its field.
Looks like a buy El, price moved marginally up a few minutes after. I can recall times last year when I purchased 75000 and mms pushed it up 12%, mind you that was at .70! Some games being played here last couple of months, unfortunately I don't have the skills or knowledge to interpret them. I haven't seen another low liquidity AIM share with such a small spread, ever. What does it mean?!!
Hi, don't live there now but place of birth so always holds a place and all that. Recent ancestry investigations taken family back to 1660 and some strong Suffolk links but still no affection for Ipswich unfortunately!
Hi El, you must be in heaven, QPR supporter and another 0.5% rise! For my sins am a lifelong Canary fan and after a great win against the enemy from Suffolk it's all gone pear shaped, again. We haven't got any money and Delias pockets are empty.
Come on guys, let's have a bit of positivity! AR is Tom Charltons mate and was recruited by him. Tom gave him 5 million shares as a welcome gift. Tom still holds up to 50 million shares and his mate is going to do his best for him. I know it's very slow but we have to believe they are working their socks off to get this product globally recognised for clinical use.
Good to hear from you and yes still smiling...
Good evening everyone, what a splendid day, first price movement in a couple of months, up 0.5%!! Another day ticked off....
Anyone planning to attend? Likely held in London.
Afternoon all. FBDU are using Texrad for the development of a product which helps clinicians with diagnosis of kidney stones. How refreshing to see today their 4th company update since mid July! It's very reassuring that some companies see the value and integrity in keeping shareholders informed of progress. Not long now?